Final analysis of potential drug–drug interactions between highly purified cannabidiol and anti‐seizure medications in an open‐label expanded access program

Abstract Objective The aim of this study was to assess potential drug–drug interactions between highly purified cannabidiol (CBD) and anti‐seizure medications (ASMs). Methods Our group previously reported that in a sample of adults and children receiving CBD in an open‐label expanded access program,...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Tyler E. Gaston, E. Martina Bebin, Gary R. Cutter, Leslie Grayson, Jerzy P. Szaflarski
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Wiley 2023-12-01
סדרה:	Epilepsia Open
נושאים:	anti‐seizure medications cannabidiol drug interactions treatment‐resistant epilepsy
גישה מקוונת:	https://doi.org/10.1002/epi4.12815
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!